Mitochondria-targeted nanomedicines for cardiovascular applications.

Tabish TA., Lygate CA.

Tweetable abstract Mitochondria are increasingly a target for drug delivery in cardiovascular diseases. This editorial describes how a nanomedicine approach may improve drug potency and efficacy in a safe and controlled manner.

DOI

10.2217/nnm-2023-0321

Type

Journal article

Journal

Nanomedicine (London, England)

Publication Date

12/2023

Addresses

Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation (BHF) Centre of Research Excellence, University of Oxford, Oxford, OX3 7BN, UK.

Permalink Original publication